Canadians bought more cannabis, less alcohol in January

January retail sales: beer, wine and liquor fell 1.3% year-over-year while cannabis retail sales rose 6.4% YoY. ATB Cormark data show per-capita alcohol consumption declined from 101.6 L in 2017 to 82.7 L in 2025, with experts citing price differentials, changing social norms post-legalization and COVID-era shifts to at-home consumption and expanded dispensary/delivery access as drivers. Analysts caution substitution is plausible but not yet definitive amid evolving health evidence and regulatory dynamics.

Analysis

The observed shift looks less like a single-product substitution and more like a change in occasion economics: cannabis lowers the per-occasion cash and hangover cost, widening its addressable occasions among younger, cost-sensitive consumers. If cannabis continues to be ~50% cheaper per ‘social use’ (as anecdotal data suggest), an elasticity regime where every 10% relative price gap re-allocates ~1–3% of drinking occasions implies alcohol volumes could decline another mid-single digits over 12–24 months absent price or format response.

Second-order winners will be last-mile retail and testing/packaging vendors (higher SKU counts, more frequent SKU turnover, and same-day delivery margins), while beverage alcohol incumbents face demand compression in on-premise channels and higher SKU rationalization costs. That creates margin pressure for brewers/distributors (inventory obsolescence, lower case throughput) and boosts commercial real estate churn—prime high-street storefronts will reprice toward dispensaries and quick-delivery dark-store economics within 6–18 months.

Key reversal catalysts are regulatory and social: tighter cannabis taxation or stricter public-use rules, conclusive health studies that change perceptions, or a sustained nightlife rebound that restores premium drink occasions. These catalysts operate on different horizons — sales prints/earnings guidance can move relative performance in weeks to months, while regulatory or demographic shifts play out over multiple years — so position sizing and explicit hedges are crucial.

Key Decisions for Investors

• Pair trade (3–12 months): Long MJ (ETFMG Alternative Harvest ETF) / Short TAP (Molson Coors) — size 3–5% net notional. Rationale: capture a sector rotation into cannabis retail/manufacturing vs incumbent macro-exposed brewer. Target 20–40% relative outperformance; stop-loss if pair reverses by 12% (protect against on-premise rebound).
• Directional defined-risk (6–9 months): Buy TLRY or CGC call spread (choose nearest 6–9 month strikes to limit premium). Rationale: convex exposure to continued retail share gains and margin expansion in vertically integrated growers. Reward: 3x+ if names re-rate; max loss = premium paid (defined).
• Hedge/contrarian (12–24 months): Small long in DEO (Diageo) or STZ (Constellation Brands) at the margin as a reversal hedge — size 1–2% as a volatility hedge. Rationale: if socializing and premium on-premise occasions recover, these high-quality FCF generators rebound; asymmetry: limited drawdown vs multi-quarter upside. Take profits on a 15–25% move higher, cut at 12% adverse move.
• Event monitor (0–6 months): Set alerts for (a) provincial tax policy announcements, (b) major cannabis retail licensing pulses, and (c) two consecutive quarterly on-premise sales re-accelerations. These are actionable triggers to reweight the pair and option positions; treat any single regulatory tightening as a binary tail risk and reduce net long cannabis exposure by at least 50% upon material unfavorable policy change.